Portfolio Lab

Medtronic plc

  • Stock
  • Ticker MDT
  • ISIN IE00BTN1Y115
  • NYSE
  • US listing in dollars

Health care · Medical technology · USA

$99.94 −0.67%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Medtronic plc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

MDTGlobal equities (VT)

$10,000 grew to $16,226. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −45.1% in 10/2023, measured from the peak in 09/2021. The old peak has not been reached again yet.

1-year return
+3.9%
5-year return p.a.
0.0%
10-year return p.a.
+5.0%
Volatility p.a.
21.5%
Largest decline
−45.1%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end10/202401/202504/202507/202510/202501/202604/202607/2026
Income statement
Revenue8,4038,2928,9278,5788,9619,0179,8079,756
Gross profit5,4575,5135,7805,5775,9005,7566,4096,340
Operating income1,5951,6461,4361,4451,6861,4641,8731,764
EBITDA1,8571,9142,2762,1931,9681,7722,5892,493
Net income1,2701,2941,0561,0401,3741,1431,2441,470
Earnings per share0.991.010.820.811.070.890.971.14
Balance sheet
Total assets90,04289,97391,68090,97291,34691,48593,02893,306
Liabilities41,32640,35843,42442,83942,48942,28942,95642,456
Equity48,49449,38748,02447,89348,65248,98549,46350,232
Cash1,3941,2402,2181,2731,2821,1471,9491,691
Cash flow
Operating cash flow9582,5722,5281,0889252,7442,5731,793
Capital expenditure-404-476-459-504-468-444-488-503
Free cash flow5542,0962,0695844572,3002,0851,290

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +27.3%, weakest 2022 at −22.5%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
3 Sep 2026$1.14
18 Jun 2026$0.97
24 Feb 2026$0.89
25 Nov 2025$1.07
26 Aug 2025$0.81
20 Jun 2025$0.82
25 Feb 2025$1.01
26 Nov 2024$0.99
27 Aug 2024$0.80
20 Jun 2024$0.49
27 Feb 2024$0.99
30 Nov 2023$0.68

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€116bn
Market cap in trading currency
$128bn
Enterprise value
$122bn
P/E
24.6
P/S
3.41
P/B
2.54
EV/Sales
3.24
EV/EBITDA
13.8
Earnings yield
4.1%
FCF yield
4.8%

Results (last four quarters)

Revenue
$37.5bn
Gross profit
$24.4bn
EBITDA
$8.82bn
Net income
$5.23bn
Earnings per share
$4.07
Revenue per share
$29.35
Revenue growth
+13.7%
Earnings growth
+41.3%

Profitability

Gross margin
65.0%
Operating margin
18.1%
Net margin
13.9%
Return on equity
10.7%
Return on assets
5.6%

Balance sheet and cash flow

Cash
$8.82bn
Cash per share
$6.89
Financial debt
$2.54bn
Debt/equity %
5
Current ratio
2.07
Book value per share
$39.27
Operating cash flow
$8.04bn
Free cash flow
$6.13bn

Dividend

Dividend yield
2.86%
Dividend (12 months)
$2.86
Yield (12 months)
2.86%
Payout ratio
70%
Ex-dividend date
25 Sep 2026

Shares and trading

Shares outstanding
1.28bn
Volume
8.91m
Avg. volume 3 months
16.7m
Relative volume
0.5

Price and technicals

Price
$99.94
1 day
−0.7%
52-week high
$105.35
52-week low
$73.75
Distance to 52-week high
−5.1%
Distance to 52-week low
+35.5%
Distance to 50-day line
+5.6%
Distance to 200-day line
+13.3%
RSI (14)
54
Volatility 1M
29.9%

Performance

1 week
−2.8%
1 month
+3.5%
3 months
+7.6%
6 months
+27.2%
YTD
+4.0%
1 year
−0.4%

Dates

Fiscal year end
24 Apr 2026
Most recent quarter
31 Jul 2026

Frequently asked questions

How has MDT performed since 11/2016?

$10,000 grew to $16,226 by 20 Nov 2026, which is +5.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is MDT?

Volatility was 21.5% per year, measured on monthly returns. The largest decline from a peak was −45.1%, with the low in 10/2023.

How does MDT compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, MDT returned +5.0% at 21.5%. The correlation of monthly returns was 0.46; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Medtronic plc (MDT): Return and risk | Portfolio Lab